Share on StockTwits

Illumina (NASDAQ:ILMN) SVP Mostafa Ronaghi sold 10,000 shares of the stock on the open market in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $179.47, for a total value of $1,794,700.00. Following the sale, the senior vice president now directly owns 28,604 shares in the company, valued at approximately $5,133,560. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

A number of research firms have recently commented on ILMN. Analysts at Zacks upgraded shares of Illumina from a “neutral” rating to an “outperform” rating in a research note on Tuesday, June 24th. They now have a $205.00 price target on the stock. Separately, analysts at Ned Davis Research upgraded shares of Illumina from a “sell” rating to a “neutral” rating in a research note on Monday, April 28th. Finally, analysts at Maxim Group upgraded shares of Illumina from a “hold” rating to a “buy” rating in a research note on Wednesday, April 23rd. They now have a $205.00 price target on the stock. Seven analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $146.71.

Shares of Illumina (NASDAQ:ILMN) traded up 2.33% on Tuesday, hitting $182.70. 1,276,787 shares of the company’s stock traded hands. Illumina has a one year low of $72.13 and a one year high of $183.30. The stock’s 50-day moving average is $163.0 and its 200-day moving average is $148.1. The company has a market cap of $23.458 billion and a P/E ratio of 125.56. Illumina also was the recipient of a large decline in short interest in the month of June. As of June 13th, there was short interest totalling 10,265,824 shares, a decline of 41.3% from the May 30th total of 17,495,888 shares. Based on an average trading volume of 2,518,211 shares, the short-interest ratio is currently 4.1 days. Approximately 8.1% of the company’s shares are short sold.

Illumina (NASDAQ:ILMN) last issued its quarterly earnings data on Tuesday, April 22nd. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.01. The company had revenue of $421.00 million for the quarter, compared to the consensus estimate of $391.50 million. During the same quarter in the previous year, the company posted $0.46 earnings per share. The company’s revenue for the quarter was up 27.2% on a year-over-year basis. Analysts expect that Illumina will post $2.17 EPS for the current fiscal year.

Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.